title: Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.
abstract: Ectopically expressed eukaryotic translation initiation factor 4E (eIF4E) stimulates cell proliferation, suppresses apoptosis in growth factor restricted cells, and induces malignant transformation in primary rodent fibroblasts when coexpressed with protooncogene myc. We report here that eIF4E rescued rat embryo fibroblasts ectopically expressing c-Myc (REF/Myc) from genotoxic and non-genotoxic cytostatic drugs and identify cyclin D1 as a downstream effector in the antiapoptotic mechanism. In clones of REF/Myc ectopically expressing eIF4E, resistance to apoptosis paralleled steady state levels of cyclin D1. Stable expression of cyclin D1 in REF/Myc inhibited apoptosis in response to a broad range of cell cycle specific cytostatic agents. Partial loss-of-cyclin D1 function in REF/Myc ectopically expressing eIF4E (REF/Myc/4E) significantly increased chemosensitivity; either soluble antisense cyclin D1 oligomers or transfection with a dominant negative cyclin D1 mutant that prevents translocation of cyclin D-dependent kinases to the nucleus, significantly blunted the antiapoptotic effect of eIF4E. These data directly link eIF4E rescue from cytostatic drugs to cyclin D1. Since overexpression of eIF4E and cyclin D1 is observed in many aggressive forms of chemoresistant cancers, these findings provide insight into possible mechanisms responsible for this biological behavior.
authors.affiliation: Department of Medicine, Pulmonary, Allergy and Critical Care Division University of Minnesota, Medical School, Minneapolis, Minnesota, MN 55255, USA.
authors.forename: A
authors.initials: A
authors.lastname: Tan
authors.forename: P
authors.initials: P
authors.lastname: Bitterman
authors.forename: N
authors.initials: N
authors.lastname: Sonenberg
authors.forename: M
authors.initials: M
authors.lastname: Peterson
authors.forename: V
authors.initials: V
authors.lastname: Polunovsky
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D002460:Cell Line; D019938:Cyclin D1 / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D018844:Cyclin-Dependent Kinases / Q000378:metabolism; D004622:Embryo, Mammalian / Q000166:cytology; D004789:Enzyme Activation / Q000187:drug effects; D039561:Eukaryotic Initiation Factor-4E; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D008148:Lovastatin / Q000494:pharmacology; D010448:Peptide Initiation Factors / Q000096:biosynthesis / Q000502:physiology*; D016271:Proto-Oncogene Proteins c-myc / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D051381:Rats
chemical_list: D039561:Eukaryotic Initiation Factor-4E; D010448:Peptide Initiation Factors; D016271:Proto-Oncogene Proteins c-myc; D019938:Cyclin D1; D008148:Lovastatin; D018844:Cyclin-Dependent Kinases